Comparison of GRS-31, GRS-18, GRS-10, GRS-proximalVDR and GRS-nonproxVDR.

αGRS-proximalVDR: additive genetic risk score used to estimate a per allele OR and 95% CI. Includes SNPs; rs3802842, rs4939827, rs10411210.βGRS-nonproxVDR: additive genetic risk score used to estimate a per allele OR and 95% CI. Includes SNPs; rs6983267, rs16892766, rs10795668, rs4444235, rs4779584, rs9929218, rs961253.χGRS-10: additive genetic risk score used to estimate a per allele OR and 95% CI. Includes SNPs; rs3802842, rs4939827, rs10411210, rs6983267, rs16892766, rs10795668, rs4444235, rs4779584, rs9929218, rs961253.δGRS-18: additive genetic risk score used to estimate a per allele OR and 95% CI. Includes SNPs; rs3802842, rs4939827, rs10411210, rs6983267, rs16892766, rs10795668, rs4444235, rs4779584, rs9929218, rs961253, rs6691170, rs6687758, rs10936599, rs10505477, rs7014346, rs7136702, rs11169552, rs2151512.εGRS-31: additive genetic risk score used to estimate a per allele OR and 95% CI based upon the subset of cases and controls with GWAS data (394 cases/772 controls in NHS; 228 cases/222 controls in HPFS; 332 cases/332 controls in PHS). Includes SNPs; rs3802842, rs4939827, rs10411210, rs6983267, rs16892766, rs10795668, rs4444235, rs4779584, rs9929218, rs961253, rs6691170, rs6687758, rs10936599, rs7136702, rs11169552, rs4925386, rs10911251, rs11903757, rs647161, rs1321311, rs719725, rs3824999, rs3217810, rs3217901, rs10774214, rs59336, rs1957636, rs11632715, rs16969681, rs2423279, rs4813802.